2023年ESMO妇科肿瘤治疗最新进展及展望

The latest progress and prospect of gynecological tumor treatment at 2023 ESMO

妇科肿瘤(宫颈癌、卵巢癌和子宫内膜癌)领域在过去1年取得了诸多重磅性研究成果,包括手术治疗方式、局部晚期治疗模式及复发转移的新治疗探索等,尤其是免疫治疗、靶向治疗和抗体药物偶联物(antibody-drug conjugate,ADC)治疗等新兴治疗方式相较于传统的治疗模式,其研究开创了治疗的新纪元,为患者带来更多的治疗希望。本文总结2023年欧洲肿瘤内科学会(European Society for Medical Oncology,ESMO)年会中妇科肿瘤在手术治疗、放疗、化疗及新型靶向免疫治疗等方面的重大进展,以期更好地指导临床个体化精准治疗。

Many major research achievements have been made in the past year in the field of gynecologic oncology(cervical cancer,ovarian cancer and endometrial cancer),including surgical treatment,local advanced treatment mode and exploration of new treatments for recurrence and metastasis.Especially the research of emerging treatment methods such as immunotherapy,targeted therapy and antibody-drug conjugate therapy has opened a new era of treatment and brought more hopes for treatment to patients.This paper summarizes the major advances in surgical treatment,radiotherapy,chemotherapy and novel targeted immunotherapy for gynecologic oncology at 2023 Annual Meeting of European Society for Medical Oncology(ESMO),in order to better guide the individualized precision treatment.